Hospital infection therapeutics market size was valued at US$ 10.5 billion in 2024 and is projected to hit the market valuation of US$ 14.7 billion by 2033 at a CAGR of 3.8% during the forecast period 2025–2033.
Radiopharmaceuticals market was valued at US$ 6.8 billion in 2024 and is projected to hit the market valuation of US$ 13.4 billion by 2033 at a CAGR of 7.8% during the forecast period 2025–2033.
Hospital supplies market size was valued at US$ 43.99 billion in 2024 and is projected to hit the market valuation of US$ 125.56 billion by 2033 at a CAGR of 12.36% during the forecast period 2025–2033.
Intraoral scanners market was valued at US$ 786.5 million in 2024 and is projected to hit the market valuation of US$ 1,794.8 million by 2033 at a CAGR of 9.6% during the forecast period 2025–2033.
Blood clot retrieval devices market was valued at US$ 1.68 billion in 2024 and is projected to hit the market valuation of US$ 5.68 billion by 2033 at a CAGR of 14.5% during the forecast period 2025–2033.
Benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is projected to hit the market valuation of US$ 16.5 billion by 2033 at a CAGR of 5.1% during the forecast period 2025–2033.
U.S. durable medical equipment market was valued at US$ 80.9 billion in 2024 and is projected to hit the market valuation of US$ 137.9 billion by 2033 at a CAGR of 6.1% during the forecast period 2025–2033.
Functional Service Providers (FSP) market was valued at US$ 17.9 billion in 2024 and is projected to hit the market valuation of US$ 38.56 billion by 2033 at a CAGR of 8.9% during the forecast period 2025–2033.